Lateral flow assays (LFAs), such as the COVID-19 rapid test, are powerful devices to rapidly detect a protein’s presence or absence. This assay is so easy to perform that it enables at-home testing, ...

In addition, it has high sensitivity and specificity, ensuring accuracy despite requiring only a low sample volume and little or no samples or reagent preparations. Amerigo Scientific’s nucleic acid ...

In health care, paper-based diagnostics have revolutionized point-of-care approaches by providing disposable, low-cost tools that can be used remotely. Developed by the World Health Organization (WHO) ...

The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care. To meet this need, scientists from the Suzhou Institute of Biomedical Engineering and ...

With increasing numbers of people suffering from coronavirus disease 2019 (COVID-19), and most recovering, the levels of protective immunity need to be measured over time to help measure the duration ...

Adoption is tempered by notable constraints. LFAs often exhibit lower sensitivity and specificity than molecular or lab-based tests, leading to false-positive or false-negative outcomes and hindering ...

Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Components Market by Type, Application, Technique, End User, and Region - Global Forecast to 2030" has been added to ...

If we could run back 2020 to its beginning and get a do-over, chances are pretty good that we’d do a lot of things differently. There’s a ton of blame to go around on COVID-19, but it’s safe to say ...

Dublin, April 28, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Market: Analysis by Product Type, Application, Technology, End User, and Region - Growth Trends and Forecast to 2030" report has been ...